Image (26a9360d 7db4 42fe B9d2 Ecddfe369d2e 01)
Atovaquone Suspension
Product Images NDC 70748-299
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 70748-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container-750mg/5ml (26a9360d 7db4 42fe B9d2 Ecddfe369d2e 02)
The text provides instructions for the usual dosage of Atovaquone Oral Suspension USP, including information on how to store the medication and the amount of atovaquone USP contained in each 5 mL dose. The medicine should not be frozen and should be dispensed in a tightly sealed container. The text also mentions that the medicine should be shaken gently before use and includes manufacturing information from Hetero Labs Limited.*
Carton-750mg/5ml (26a9360d 7db4 42fe B9d2 Ecddfe369d2e 03)
Atovaquone Oral Suspension is a medication that contains 750mg of atovaquone per 5 mL. It is used to treat certain parasitic infections. This medication should be stored at room temperature and should not be frozen. Before usage, it needs to be gently shaken. This medication is manufactured by Lupin Pharmaceuticals and Hetero Labs Limited.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
